Navidea Biopharmaceuticals files patent for polymeric compound for treating diseases involving macrophages
According to GlobalData’s company profile on Navidea Biopharmaceuticals, Isotropically modified heterocyclic compounds was a key innovation area identified from patents. Navidea Biopharmaceuticals's grant share as of January 2024 was 44%. Grant share …